Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-16

Clinical Trial Update: Analgesic Effect of Liposomal Bupivacaine [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing analgesic effect of liposomal bupivacaine in acute pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: The University of Hong Kong | Conditions: Acute Pain | Phase 4 | Status: COMPLETED